Salumag, Geraldine C.
HRN: 22-93-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/21/2023
04/27/2023
IV
500mg
TID
S/P LTCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes